225 followers
RT @EHF_Official: Erenumab was licensed in Switzerland in 2018 for the prophylactic treatment of migraine. A observational study was design…
RT @EHF_Official: Erenumab was licensed in Switzerland in 2018 for the prophylactic treatment of migraine. A observational study was design…
Erenumab was licensed in Switzerland in 2018 for the prophylactic treatment of migraine. A observational study was designed to collect and evaluate clinical data on the impact of erenumab on several endpoints, read the interim results here: https://t.co/Qr